Manganese (Mn) is a common metal in welding fume aerosols and suspected of inducing adverse neurological effects in exposed workers. Measurements of Mn in blood and urine have proven to be unreliable indicators of exposure. The goal of the current study was to determine if Mn accumulation in the nail (claw) can be used as a potential biomarker. To model this, male Sprague-Dawley rats were treated by intratracheal instillation (IT) with 2 mg/rat of shielded manual metal arc-hardsurfacing (MMA-HS; high Mn) or gas metal arc -mild steel (GMA-MS; low Mn) welding fumes once a week for 28 weeks. Vehicle controls received saline by IT. The percentage of Mn, relative to the other metals in the collected fume, was more than double (50.9 %) in the MMA-HS fume compared to GMA-MS (21.7 %). At 7 days after the last exposure, right lung lobes, specific brain regions, blood, and nails were harvested from each group. Mn levels were determined by inductively coupled plasma atomic emission spectroscopy. Significant elevations in lung Mn were observed following repeated exposure to MMA-HS and GMA-MS fumes for 28 weeks. Despite the difference in Mn composition of the two fumes, repeated exposure to equal mass doses of the fumes produced comparable Mn lung burden, suggesting a steady-state may have been achieved. Measurements of blood Mn were near or at the limit of detection and, as a consequence, variable. In contrast, Mn levels significantly increased in the nails, as well as in striatum and midbrain, potential targets of Mn neurotoxicity, for the MMA-HS group compared to the GMA-MS group and controls. Our results demonstrate nail Mn to be a potentially viable and sensitive biomarker for welding fume exposure. The ease with which nails can be harvested, transported, and stored makes them an attractive surrogate for monitoring exposures in occupational settings.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.